The GSEA showed obvious suppression of CXCL12 and CXCR4 pathway genes in NPM1-mutated patients compared to NPM1-wild AML and normal controls (normalized P-values of both <0.001, Table S3; enrichment plots, Figure 6C–D). The gene discussed is CXCR4; the disease is acute myeloid leukemia.